- RNDr. Eva KučerováHead of Regulatory Affairs, Qualified Person
- Serhiy Forostyak, MD, Ph.D.CSO
- Ing. Petr Koška, MBACEO
- Mgr. Iveta MinaříkováHead of Amnio based products
- Mgr. Igor HlásenskýHead of Legal Department
- Elen Šťastná, MDHead of PR & Marketing Dept.
RNDr. Eva Kučerová
Eva Kučerová received her degree at the Masaryk University Brno in microbiology and molecular biology. As of 2005, she has been involved in the area of research within the field of mesenchymal stem cells and cell cultivations. In the meantime, she has also participated in a variety of clinical studies and for a period of five years she has been working as a research fellow in treatments of leukaemia at the Faculty of Medicine at the Masaryk University Brno. In 2008 she was named the Head of the Cell Therapy Department at Tissue Bank at the University Hospital Brno. Since 2009 she has worked as Qualified Person and in the same year she has been appointed Head of the Department of Cell Transplants at the National Cell and Tissue Centre. She is also responsible for clinical trials.
Actively participating at national and international conferences, presenting new research findings, Eva Matějková is a renowned professional within the field of Advanced Therapies.
Serhiy Forostyak, MD, Ph.D.
Dr. Forostyak has graduated from a Faculty of Medicine at Ternopil’ State Medical University, Ukraine in 2005 (with honours). After receiving his first degree specialization in the field of general surgery (2008) Dr. Forostyak has continued his education at the 2nd Faculty of Medicine at Charles University in Prague and Institute of Experimental Medicine at Czech Academy of Sciences.
He has defended his doctoral thesis in 2012 and received a title PhD in Neuroscience. During his doctoral and postdoctoral years he has received several prestigious fellowships and awards (CORTEX: Marie Curie Early Stage Training Net; FENS Young Investigator Training Program; Czech Neuroscience Society award for best publication published by a Young Neuroscientist; Development of Research Teams for the BIOCEV; EUROCELLNET travel fellowship etc.) and underwent internship in prestigious universities (Cambridge University, UK; Katholieke Universiteit Leuven, Belgium; Neuroscience Institute Cavalieri Ottolenghi, Italy; University of Pittsburgh, USA). Dr. Forostyak’s research lays in the field of regenerative and translational medicine with a main focus on evaluation of regenerative potential of stem cells (mesenchymal stromal cells; embryonic stem cells; induced pluripotent stem cells etc.) and biomaterials, and their application to cure neurotrauma and neurodegenerative disorders. Current scientific record includes 22 publications (WOS) in prestigious international peer-reviewed journals, 3 book chapters and 3 papers are currently in press. Dr. Forostyak has been principal/co-principle investigator in several research projects. He is acting as a scientific evaluator of national and international grant agencies, but also contributes as a reviewer in prestigious scientific journals. He has been actively participating at numerous national and international conferences, but also acted as an organising committee member at several international meetings.
Ing. Petr Koška, MBA
Petr Koška, CEO PrimeCell and Vice-Chairman of the Board, of the National Cell and Tissue Centre Inc. (one of the subsidiaries of PrimeCell). He joined PrimeCell in January 2013. Petr Koska is in the field of medicine since 1993, he is a well-known professional within the healthcare industry in the Czech Republic.
Since 2008, he was CEO at one of the largest university hospitals in the Czech Republic, namely, St. Anne´s University hospital Brno. In his position he gained knowledge of transferring medical science and research into clinical practice. Additionally, he was the head of a unique team of professionals who were developed in co-operation with Mayo Clinic, Rochester, Minnesota, USA an International centre of clinical research within the premises of St. Anne´s hospital, namely, International Clinical Research Center (ICRC).
He started his professional career in 1996 at the University hospital Brno, where he held various leading positions until 2007, when he was elected General Director. In 1997 – 1998 he was one of the three key figures involved in the most unique plan in the healthcare industry in the Czech Republic up-to-date, which was the merger of university hospitals in the Brno region. Petr Koška graduated at the Technical University Brno. Later, he obtained the MBA degree at Prague International Business School. Currently he is the candidate for PhD in business (DBA). In 2008 – 2012 he was a member of the scientific committee at the Medical faculty of Masaryk University in Brno.
Mgr. Iveta Minaříková
Iveta je se svými zkušenostmi z farmaceutického odvětví jako vědecko-vývojový pracovník odpovědná v Primecell za vývoj nových produktů a oblast zpracování specifických tkání a buněk.
Vystudovala obor Analytická biochemie na Přírodovědecké fakultě Masarykovy univerzity v Brně. V průběhu vysokoškolského studia absolvovala stáž na Veterinární a farmaceutické univerzitě v Brně. Je vítězem národní soutěže Science Slam a zúčastnila se celoevropského finále ve Vídni, se svou diplomovou prací na výzkumu věnujícímu se problematice prevence hypoglykémie. Jednalo se o formulaci a následně testování mikrolékových forem s vysokým obsahem glukózy a semipermeabilní membránou, která zajišťovala postupné uvolňování glukózy. S tímto výzkumem vyhrála, popularizující současný výzkum a vědu, a následně se zúčastnila celoevropského finále ve Vídni.
Před nástupem do Primecell pracovala ve společnosti Oncomed Manufacturing.
Mgr. Igor Hlásenský
Legal matters of PrimeCell are in hands of a team of in-house lawyers led by Igor Hlásenský, young but well-experienced specialist in medical law as well as commercial and administrative law. Upon finishing his studies at the Faculty of Law of Masaryk University in Brno in 2010, he worked for a respected law firm and later moved up to the Ministry of Health to became a main lawyer, inspector, and deputy head of Inspectorate of narcotic drugs and psychotropic substances.
Igor was a part of the European Commission team in Serbia, to help to bring this country’s legislation under the European lagislation. Igor is a major author of the text of the Czech Act On Drug Precursors and certain other general binding regulations and contributed significantly to terminate complicated and hyped cases. Nowadays Igor is ranked among leading experts in legal obligations related to handling with tissues and cells.
Elen Šťastná, MD
Dr. Elen Šťastná graduated from Charles University in Hradec Kralové in general medicine. After obtaining a first degree specialization in the field of general medicine she worked in this field until 2000. She has been involved in the projects of preventive medicine and projects aimed at improving the quality of life. She has worked at the Danish pharmaceutical and nutraceutical company Pharma Nord at managerial position in the field of education. Dr. Šťastná also provides consulting and advisory services in marketing communications activities, strategic planning and PR. She is The President of Soroptimist International Prague-world, prestigious women’s organizations with direct access to the UN and other international organizations, such as UNESCO and the Council of Europe. Soroptimist International seeks to improve access to health care, doctors, midwives and applies to the fight against the spread of AIDS and transmission of the disease from mother to newborn and improvement of living conditions of women and children.
Dr. Štastná is the founder of the AA Homolka Club at the Department of Pediatric Allergy and Clinical Immunology Hospital Homolka, whose activities contribute to the improvement of awareness and better care for children with allergy and asthma.